To the best of our knowledge, there are no reports to this date on the role of AXL–GAS6 in NSCLC BM, and the prognostic significance of AXL–GAS6 expression in lung cancer brain metastases remains undefined. This evidence concerns the gene GAS6 and lung cancer.